MedPath
NMPA Approval

硝苯地平

国药准字H44021513

July 8, 2021

国药准字H44021513

Drug Information

硝苯地平

原料药

化学药品

July 8, 2021

Company Information

Applicant Company

Manufacturing Company

汕头市泰山路36号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硝苯地平 - NMPA 批准文号 | MedPath